Total Payments
$361.57
2024 Payments
$34.44
Companies
10
Transactions
17
Medicare Patients
8,160
Medicare Billing
$480,395
Payment Breakdown by Category
Food & Beverage$361.57 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $361.57 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $114.41 | 4 | $0 (2023) |
| Amgen Inc. | $77.32 | 4 | $0 (2024) |
| Nevro Corp. | $39.27 | 2 | $0 (2022) |
| PFIZER INC. | $30.68 | 1 | $0 (2023) |
| Ascensia Diabetes Care US Inc. | $24.14 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $17.83 | 1 | $0 (2019) |
| Amphastar Pharmaceuticals, Inc. | $15.42 | 1 | $0 (2023) |
| Echosens North America, Inc. | $15.34 | 1 | $0 (2023) |
| Zealand Pharma US, Inc. | $14.67 | 1 | $0 (2022) |
| Medtronic MiniMed, Inc. | $12.49 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.44 | 2 | Amgen Inc. ($34.44) |
| 2023 | $175.85 | 7 | Novartis Pharmaceuticals Corporation ($114.41) |
| 2022 | $96.82 | 5 | Amgen Inc. ($42.88) |
| 2021 | $24.14 | 1 | Ascensia Diabetes Care US Inc. ($24.14) |
| 2020 | $12.49 | 1 | Medtronic MiniMed, Inc. ($12.49) |
| 2019 | $17.83 | 1 | Gilead Sciences, Inc. ($17.83) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Bone Health | ||||||
| 02/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Bone Health | ||||||
| 12/04/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: VACCINES | ||||||
| 12/04/2023 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 08/17/2023 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Elastography | ||||||
| 06/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/02/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/26/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/12/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Bone Health | ||||||
| 10/04/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/08/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Bone Health | ||||||
| 01/18/2022 | Zealand Pharma US, Inc. | ZEGALOGUE (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 12/09/2021 | Ascensia Diabetes Care US Inc. | — | Food and Beverage | In-kind items and services | $24.14 | General |
| 09/09/2020 | Medtronic MiniMed, Inc. | Guardian Connect (Device) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 03/04/2019 | Gilead Sciences, Inc. | Letairis (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: PAH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,781 | 4,270 | $317,529 | $119,015 |
| 2022 | 25 | 1,652 | 4,037 | $297,769 | $106,282 |
| 2021 | 31 | 2,663 | 5,514 | $429,155 | $152,459 |
| 2020 | 29 | 2,064 | 4,164 | $330,104 | $102,638 |
Total Patients
8,160
Total Services
17,985
Medicare Billing
$480,395
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 295 | 444 | $121,656 | $40,541 | 33.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 1,920 | $52,704 | $35,285 | 66.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 80 | 82 | $24,518 | $7,363 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $17,974 | $5,014 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 36 | $13,284 | $4,859 | 36.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 115 | 136 | $14,960 | $3,945 | 26.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 176 | 225 | $13,950 | $3,692 | 26.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 259 | 385 | $4,235 | $3,217 | 76.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 46 | 63 | $9,639 | $2,519 | 26.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 15 | 17 | $5,491 | $1,838 | 33.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 149 | 186 | $6,138 | $1,638 | 26.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 110 | 144 | $5,616 | $1,490 | 26.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 28 | 54 | $4,968 | $1,382 | 27.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 87 | 142 | $5,112 | $1,342 | 26.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 103 | 130 | $4,030 | $1,078 | 26.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 43 | 56 | $3,528 | $929.60 | 26.3% |
| 88172 | Evaluation of fine needle aspirate | Office | 2023 | 15 | 17 | $2,516 | $782.68 | 31.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 23 | 26 | $910.00 | $665.93 | 73.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 41 | 42 | $2,100 | $541.68 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 32 | $2,080 | $326.48 | 15.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 29 | 36 | $1,044 | $273.96 | 26.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 27 | 29 | $551.00 | $147.32 | 26.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 24 | 25 | $525.00 | $141.50 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 282 | 405 | $110,970 | $35,051 | 31.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 20 | 1,861 | $51,084 | $31,521 | 61.7% |
About Dr. Scott Grady, MD
Dr. Scott Grady, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396893897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Grady, MD has received a total of $361.57 in payments from pharmaceutical and medical device companies, with $34.44 received in 2024. These payments were reported across 17 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($361.57).
As a Medicare-enrolled provider, Grady has provided services to 8,160 Medicare beneficiaries, totaling 17,985 services with total Medicare billing of $480,395. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Portland, OR
- Active Since 01/08/2007
- Last Updated 03/07/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1396893897
Products in Payments
- LEQVIO (Drug) $80.64
- EVENITY (Biological) $77.32
- Omnia (Device) $39.27
- ENTRESTO (Drug) $33.77
- PREVNAR 20 (Biological) $30.68
- Letairis (Drug) $17.83
- BAQSIMI (Drug) $15.42
- FibroScan (Device) $15.34
- ZEGALOGUE (Drug) $14.67
- Guardian Connect (Device) $12.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Portland
Mr. Michael Mcclung, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.6M
Endocrinology, Diabetes & Metabolism $1.6M
James Neifing, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $475,019
Endocrinology, Diabetes & Metabolism $475,019
Maria Fleseriu, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $418,716
Endocrinology, Diabetes & Metabolism $418,716
Rodica Busui, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $211,479
Endocrinology, Diabetes & Metabolism $211,479
Jonathan Purnell, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $209,631
Endocrinology, Diabetes & Metabolism $209,631
Nancy Curosh, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $194,307
Endocrinology, Diabetes & Metabolism $194,307